Blueprint Medicines (United States)
- World rank, all time
- #19,502 of 34,923
- Rank in United States
- #4,047 of 7,310
- Research works
- 199 ▲ 33% vs 2018-21
- Citations
- 8.5k 42.7 per fractional work
- Top-10% rate
- 12.4% all institutions 10.0%
- vs its own fields
- 1.00× 1.00× is exactly expected
- Open access
- 67% world 40%
- International
- 19% world 18%
Which fields of science does Blueprint Medicines (United States) work in?
In 2022-now, 34% of research at Blueprint Medicines (United States) is in Health Sciences, 30% in Physical Sciences. Its largest fields are Medicine (33%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (10%). It does 1.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 25 fields, with their numbers
- Health Sciences3634.2%
- Medicine3533.0%
- Health Professions11.1%
- Veterinary00.1%
- Nursing00.1%
- Physical Sciences3229.9%
- Engineering76.4%
- Computer Science66.1%
- Physics and Astronomy55.0%
- Environmental Science43.3%
- Earth and Planetary Sciences32.9%
- Chemistry32.8%
- Energy21.9%
- Materials Science10.8%
- Chemical Engineering10.6%
- Mathematics00.1%
- Life Sciences2826.6%
- Social Sciences109.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.4×. Every wedge is a field page.
All 25 fields, with their numbers
- Immunology and Microbiology10.43×11 works
- Decision Sciences2.68×3 works
- Biochemistry, Genetics and Molecular Biology2.50×14 works
- Physics and Astronomy2.26×5 works
- Energy2.05×2 works
- Pharmacology, Toxicology and Pharmaceutics2.00×1 works
- Earth and Planetary Sciences1.86×3 works
- Chemical Engineering1.80×1 works
- Chemistry1.77×3 works
- Medicine1.72×35 works
- Economics, Econometrics and Finance1.01×2 works
- Neuroscience0.79×1 works
- Computer Science0.79×6 works
- Environmental Science0.67×4 works
- Psychology0.56×2 works
- Veterinary0.52×0 works
- Engineering0.43×7 works
- Health Professions0.42×1 works
- Materials Science0.22×1 works
- Agricultural and Biological Sciences0.17×1 works
- Social Sciences0.16×2 works
- Arts and Humanities0.12×0 works
- Nursing0.11×0 works
- Business, Management and Accounting0.11×0 works
- Mathematics0.09×0 works
- Immunology and Microbiology 10.4×
- Decision Sciences 2.7×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Physics and Astronomy 2.3×
- Energy 2.0×
- Pharmacology, Toxicology and Pharmaceutics 2.0×
- Earth and Planetary Sciences 1.9×
- Chemical Engineering 1.8×
- Chemistry 1.8×
- Medicine 1.7×
- Economics, Econometrics and Finance 1.0×
- Neuroscience 0.8×
- Computer Science 0.8×
- Environmental Science 0.7×
- Psychology 0.6×
- Veterinary 0.5×
- Engineering 0.4×
- Health Professions 0.4×
- Materials Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
- Arts and Humanities 0.1×
- Nursing 0.1×
- Business, Management and Accounting 0.1×
- Mathematics 0.1×
Who are the top researchers at Blueprint Medicines (United States)?
Ranked on the quality score, Klaus P. Hoeflich, Beni B. Wolf and Stefanie S. Schalm lead among researchers whose main affiliation is Blueprint Medicines (United States).
- 1
Klaus P. Hoeflich
United States · #69,697 worldwide 12k citations · 279 works
- 2
Beni B. Wolf
United States · #96,820 worldwide 11k citations · 243 works
- 3
Stefanie S. Schalm
United States · #304,451 worldwide 5.4k citations · 61 works
- 4
Victoria E. Brown
United States · #326,175 worldwide 2.2k citations · 108 works
- 5
Lucian DiPietro
United States · #514,742 worldwide 1.8k citations · 68 works
- 6
Huimin Lin
United States · #597,703 worldwide 3.6k citations · 150 works
- 7
Alexandra K. Gardino
United States · #613,597 worldwide 2.2k citations · 39 works
- 8
Alexandra R. Grassian
United States · #639,019 worldwide 3.5k citations · 72 works
- 9
Erica K. Evans
United States · #706,933 worldwide 3k citations · 85 works
- 10
Chaoyang Ye
United States · #875,696 worldwide 2.7k citations · 84 works
Which keywords describe research at Blueprint Medicines (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Immune Responses, Cytokines, Allergic Disease, Mast Cells, Clinical Trials, Asthma and Chemotherapy.
- Cell Cycle
- Genetic Variants
- Genome Analysis
- Chimera States
- Development
- Chronic Spontaneous Urticaria
- Autoantibodies
- Synchronization
- Metastasis
- Nonlinear Dynamics
- Palbociclib
- CDK4/6 Inhibitors
- Prognostic Factors
- Eosinophils
- Metastatic Breast Cancer
- Asthma
- Chemotherapy
- Epidemiology
- Cytokines
- Immune Responses
- Inflammation
- Allergic Disease
- Mast Cells
- Clinical Trials
- Treatment
- Breast Cancer
- Allergic Diseases
- Targeted Therapy
- Quality of Life
- Immunotherapy
- Cancer Therapy
- Diagnosis
- Management
- Treatment Guidelines
- Autoimmune
- Urticaria
- ALK Inhibitors
- EGFR Mutations
- Reaction-Diffusion Model
- Mutation
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation14▲ 6.1×11 topics
- Immune Responses9▲ 57×2 topics
- Allergic Disease9▲ 557×1 topic
- Cytokines9▲ 28×2 topics
- Mast Cells9▲ 557×1 topic
- Epidemiology6▲ 1.31×14 topics
- Clinical Trials5▲ 7.4×6 topics
- Chemotherapy5▲ 6.7×9 topics
- Treatment5▲ 3.9×10 topics
- Asthma5▲ 46×3 topics
- Breast Cancer4▲ 17×4 topics
- Metastatic Breast Cancer4▲ 72×2 topics
- Allergic Diseases4▲ 70×1 topic
- Eosinophils4▲ 70×1 topic
- Targeted Therapy4▲ 18×4 topics
- Prognostic Factors4▲ 8.7×9 topics
- Quality of Life4▲ 2.6×6 topics
- CDK4/6 Inhibitors4▲ 127×1 topic
- Immunotherapy4▲ 4.9×11 topics
- Palbociclib4▲ 127×1 topic
- Cancer Therapy4▲ 6.1×8 topics
- Nonlinear Dynamics3▲ 14×3 topics
- Diagnosis3▲ 3.2×9 topics
- Metastasis3▲ 7.6×4 topics
- Management3▲ 3.2×4 topics
- Synchronization3▲ 21×2 topics
- Treatment Guidelines2▲ 11×2 topics
- Autoantibodies2▲ 9.8×4 topics
- Autoimmune2▲ 50×2 topics
- Chronic Spontaneous Urticaria2▲ 103×1 topic
- Urticaria2▲ 103×1 topic
- Development2▲ 5.6×4 topics
- ALK Inhibitors2▲ 30×1 topic
- Chimera States2▲ 72×1 topic
- EGFR Mutations2▲ 30×1 topic
- Genome Analysis2▲ 19×2 topics
- Reaction-Diffusion Model2▲ 72×1 topic
- Genetic Variants2▲ 10×2 topics
- Mutation2▲ 10×2 topics
- Cell Cycle2▲ 48×2 topics
Which research topics does Blueprint Medicines (United States) publish most on?
By volume in 2022-now: Mast cells and histamine, Asthma and respiratory diseases, Advanced Breast Cancer Therapies and Urticaria and Related Conditions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Mast cells and histamine Immunology 9 works
- 2 Asthma and respiratory diseases Physiology 4 works
- 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 4 Urticaria and Related Conditions Rheumatology 2 works
- 5 Nonlinear Dynamics and Pattern Formation Computer Networks and Communications 2 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 7 Lung Cancer Research Studies Oncology 2 works
- 8 Cancer-related Molecular Pathways Oncology 2 works
- 9 Marine and coastal ecosystems Oceanography 1 works
- 10 Microbial Community Ecology and Physiology Ecology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Blueprint Medicines (United States)'s research output changed?
Output in 2022-2025 was 33% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Blueprint Medicines (United States) as a percentage of every work published that year, 0.00026% in 2024.
Fractional works of Blueprint Medicines (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- National Bureau of Economic Research
- World Wide Web Consortium
- Biogen (United States)
- Draper Laboratory
- Cambridge Health Alliance
- Harvard Global Health Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Blueprint Medicines (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
